A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

Clinical trial NCT06899217 · COMPLETED

Trial details

NCT number: NCT06899217
Sponsor: CinDome Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Gastroparesis

Start date: 2025-01-29
Primary completion: 2026-05-07
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.